Cargando…
Management of urethral atrophy after implantation of artificial urinary sphincter: what are the weaknesses?
The use of artificial urinary sphincter (AUS) for the treatment of stress urinary incontinence has become more prevalent, especially in the “prostate-specific antigen (PSA)-era”, when more patients are treated for localized prostate cancer. The first widely accepted device was the AMS 800, but since...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958987/ https://www.ncbi.nlm.nih.gov/pubmed/31736473 http://dx.doi.org/10.4103/aja.aja_110_19 |